Follow
Simon J Allison
Simon J Allison
Reader/Associate Prof, University of Huddersfield
Verified email at hud.ac.uk
Title
Cited by
Cited by
Year
RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors
AG Winter, G Sourvinos, SJ Allison, K Tosh, PH Scott, DA Spandidos, ...
Proceedings of the National Academy of Sciences 97 (23), 12619-12624, 2000
1782000
SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways
SJ Allison, JO Milner
Cell cycle 6 (21), 2669-2677, 2007
1752007
JNK2-dependent regulation of SIRT1 protein stability
J Ford, S Ahmed, S Allison, M Jiang, J Milner
Cell cycle 7 (19), 3091-3097, 2008
1582008
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD (H)-dependent and (ii) p53-independent pathways
SJ Allison, JRP Knight, C Granchi, R Rani, F Minutolo, J Milner, ...
Oncogenesis 3 (5), e102-e102, 2014
1452014
Development and characterization of a microfluidic model of the tumour microenvironment
JM Ayuso, M Virumbrales-Muņoz, A Lacueva, PM Lanuza, ...
Scientific reports 6 (1), 36086, 2016
1422016
CK2 forms a stable complex with TFIIIB and activates RNA polymerase III transcription in human cells
IM Johnston, SJ Allison, JP Morton, L Schramm, PH Scott, RJ White
Molecular and cellular biology 22 (11), 3757-3768, 2002
1072002
Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription
JE Sutcliffe, TRP Brown, SJ Allison, PH Scott, RJ White
Molecular and cellular biology, 2000
982000
RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130
JE Sutcliffe, CA Cairns, A McLees, SJ Allison, K Tosh, RJ White
Molecular and cellular biology, 1999
811999
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice
ES Polson, VB Kuchler, C Abbosh, EM Ross, RK Mathew, HA Beard, ...
Science translational medicine 10 (454), eaar2718, 2018
712018
Hypoxia-sensitive metal β-ketoiminato complexes showing induced single-strand DNA breaks and cancer cell death by apoptosis
RM Lord, AJ Hebden, CM Pask, IR Henderson, SJ Allison, SL Shepherd, ...
Journal of Medicinal Chemistry 58 (12), 4940-4953, 2015
712015
Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands
SJ Allison, M Sadiq, E Baronou, PA Cooper, C Dunnill, NT Georgopoulos, ...
Cancer letters 403, 98-107, 2017
702017
Remodelling chromatin on a global scale: a novel protective function of p53
SJ Allison, J Milner
Carcinogenesis 25 (9), 1551-1557, 2004
672004
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment
SM Elkashef, SJ Allison, M Sadiq, HA Basheer, G Ribeiro Morais, ...
Scientific reports 6 (1), 33026, 2016
642016
Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells
SJ Allison, M Jiang, J Milner
Aging 1 (3), 316, 2009
632009
SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53
CJ Lynch, ZH Shah, SJ Allison, SU Ahmed, J Ford, LJ Warnock, H Li, ...
PloS one 5 (10), e13502, 2010
572010
Anticancer metallohelices: nanomolar potency and high selectivity
RA Kaner, SJ Allison, AD Faulkner, RM Phillips, DI Roper, SL Shepherd, ...
Chemical Science 7 (2), 951-958, 2016
562016
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy
SJ Allison, J Milner
Cancer research 63 (20), 6674-6679, 2003
552003
Ruthenium‐containing linear helicates and mesocates with tuneable p53‐selective cytotoxicity in colorectal cancer cells
SJ Allison, D Cooke, FS Davidson, PIP Elliott, RA Faulkner, HBS Griffiths, ...
Angewandte Chemie International Edition 57 (31), 9799-9804, 2018
462018
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors
M Ahmadi, Z Ahmadihosseini, SJ Allison, S Begum, K Rockley, M Sadiq, ...
British journal of pharmacology 171 (1), 224-236, 2014
432014
Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target
HBS Griffiths, C Williams, SJ King, SJ Allison
Biochemical Society Transactions 48 (3), 733-744, 2020
422020
The system can't perform the operation now. Try again later.
Articles 1–20